Compounding Pharmacy Market by Therapeutic Areas (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, and Nutritional Supplements), Products (Oral, Topical, Parenteral, Nasal, and Others), Compounding Types (Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing and Pharmaceutical Dosage Alteration) and Geography – Global Forecast up to 2026
A compounding Pharmacy is a pharmacy run by a licensed pharmacist, physician, or a person by the guidance of a licensed pharmacist. It is not similar to the traditional pharmacy up to some level. However, the compounding pharmacies develop drugs prescribed by a physician as per the patient-specific requirement, which is a key objective. The Compounding Pharmacy Market is anticipated to grow at the rate of 6.2% CAGR by 2026. The market for Compounding Pharmacies is projected to boom, owing to the growing aging baby boomers population in requirement of personalized medications due to the rising prevalence of chronic diseases among this population. Since the rising elderly population and the increasing life expectancy have fostered the adoption rate of customized medicines around the world. Moreover, the rising patent exposures are also key growth propellant factors in the compounding pharmacy market. The high cost of maintaining the sterile environment and the absence of efficient regulations in several regions may limit the Compounding Pharmacy market.
Compounding Pharmacy Market based on Therapeutic Areas
As per the compound types, the pharmaceutical dosage alteration segment has the largest share in the compounding pharmacies market. The senior population experiencing pain because of chronic diseases generally requires compounded drugs customized based on the patient’s requirement. Other allopathic drugs cause adverse reactions in old individuals suffering from chronic diseases that surge the compounded drugs' demand.
Based on the products, the oral segment held a substantial share in the compounding pharmacies market due to the growing demand from patients for oral medications because of ease of administration and transportation.
Geographically, the North American region is anticipated for the large share of the market and is likely to continue its domination during the forecasted period due to the senior population's growth, scarcity of drugs, and high healthcare awareness among the public. Moreover, the increasing government initiatives favor the compounding pharmacies and the existence of advanced healthcare infrastructure facilities in this region.
The world is facing a rapid shortage of drugs, which has caused problems for health care facilities, clinicians, patients, and federal regulators. Problems in production, acquisition of raw materials, regulatory issues and business arrangements, and interruptions in the supply chain are the key factors causing drug shortage. Healthcare professionals, mainly pharmacists and drug manufacturers, are constantly working on managing the shortage of drugs. Health care professionals have started formulating solutions to control drug shortages. Hence, compounding pharmacies are considered a viable source of drugs that are in short supply.
Belle Sant? Diagnostic & Therapeutic Institute Pvt. Ltd, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy, Fagron, Inc., and US Compounding Inc are some of the competitors that are dominating the compounding pharmacy market.
Therefore, compounding pharmacies have a prominent role in offering access to discontinued medications by reproducing pharmaceutical-based ingredients to ensure that patients get the critical care they need. Presently, compounding pharmacies can access superior quality pharmaceutical ingredients and fill the prescription using the latest research.
Compounding Pharmacy Market based on Therapeutic Areas
- Hormone Replacement
- Pain Management
- Dermatology Applications
- Specialty Drugs
- Nutritional Supplements
- Oral
- Topical
- Parenteral
- Nasal
- Others
- Pharmaceutical Ingredient Alteration,
- Currently Unavailable Pharmaceutical Manufacturing,
- Pharmaceutical Dosage Alteration,
- North America
- Europe
- Asia Pacific
- Rest of the World
As per the compound types, the pharmaceutical dosage alteration segment has the largest share in the compounding pharmacies market. The senior population experiencing pain because of chronic diseases generally requires compounded drugs customized based on the patient’s requirement. Other allopathic drugs cause adverse reactions in old individuals suffering from chronic diseases that surge the compounded drugs' demand.
Based on the products, the oral segment held a substantial share in the compounding pharmacies market due to the growing demand from patients for oral medications because of ease of administration and transportation.
Geographically, the North American region is anticipated for the large share of the market and is likely to continue its domination during the forecasted period due to the senior population's growth, scarcity of drugs, and high healthcare awareness among the public. Moreover, the increasing government initiatives favor the compounding pharmacies and the existence of advanced healthcare infrastructure facilities in this region.
The world is facing a rapid shortage of drugs, which has caused problems for health care facilities, clinicians, patients, and federal regulators. Problems in production, acquisition of raw materials, regulatory issues and business arrangements, and interruptions in the supply chain are the key factors causing drug shortage. Healthcare professionals, mainly pharmacists and drug manufacturers, are constantly working on managing the shortage of drugs. Health care professionals have started formulating solutions to control drug shortages. Hence, compounding pharmacies are considered a viable source of drugs that are in short supply.
Belle Sant? Diagnostic & Therapeutic Institute Pvt. Ltd, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy, Fagron, Inc., and US Compounding Inc are some of the competitors that are dominating the compounding pharmacy market.
Therefore, compounding pharmacies have a prominent role in offering access to discontinued medications by reproducing pharmaceutical-based ingredients to ensure that patients get the critical care they need. Presently, compounding pharmacies can access superior quality pharmaceutical ingredients and fill the prescription using the latest research.
- To examine and analyze the compounding pharmacy market size by key regions, therapeutic areas, products, and compound type.
- To understand the structure of the compounding pharmacy market by recognizing its various sub-segments.
- Emphasizes the key global compounding pharmacy competitors, defining, describing, and analyzing the market competition landscape, market share, value, SWOT analysis, and development plans in the next few years.
- To analyze the compounding pharmacy market in terms of individual growth trends, prospects, and contributions to the whole market.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. THERAPEUTIC AREAS: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Hormone Replacement
5.3. Pain Management
5.4. Dermatology Applications
5.5. Specialty Drugs
5.6. Nutritional Supplements
6. PRODUCTS: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Oral
6.3. Topical
6.4. Parenteral
6.5. Nasal
6.6. Others
7. COMPOUNDING TYPES: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Pharmaceutical Ingredient Alteration
7.3. Currently Unavailable Pharmaceutical Manufacturing
7.4. Pharmaceutical Dosage Alteration
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. Belle Sant? Diagnostic & Therapeutic Institute Pvt. Ltd
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. PharMEDium Healthcare Holdings, Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Fresenius Kabi AG
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Elixir Compounding Pharmacy
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Avella specialty pharmacy
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. B. Braun Melsungen AG
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Triangle Compounding Pharmacy
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Vertisis Custom Pharmacy
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Fagron, Inc.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. US Compounding Inc
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. THERAPEUTIC AREAS: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Hormone Replacement
5.3. Pain Management
5.4. Dermatology Applications
5.5. Specialty Drugs
5.6. Nutritional Supplements
6. PRODUCTS: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Oral
6.3. Topical
6.4. Parenteral
6.5. Nasal
6.6. Others
7. COMPOUNDING TYPES: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Pharmaceutical Ingredient Alteration
7.3. Currently Unavailable Pharmaceutical Manufacturing
7.4. Pharmaceutical Dosage Alteration
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. Belle Sant? Diagnostic & Therapeutic Institute Pvt. Ltd
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. PharMEDium Healthcare Holdings, Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Fresenius Kabi AG
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Elixir Compounding Pharmacy
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Avella specialty pharmacy
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. B. Braun Melsungen AG
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Triangle Compounding Pharmacy
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Vertisis Custom Pharmacy
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Fagron, Inc.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. US Compounding Inc
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR HORMONE REPLACEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PAIN MANAGEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR DERMATOLOGY APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR SPECIALTY DRUGS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NUTRITIONAL SUPPLEMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PARENTERAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NASAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL INGREDIENT ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR CURRENTLY UNAVAILABLE PHARMACEUTICAL MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL DOSAGE ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 17. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 18. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 19. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 20. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 21. U.S COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 22. U.S COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 23. U.S COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 24. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 25. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 26. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 27. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 28. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 29. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 30. EUROPE COMPOUNDING PHARMACY MARKET VALUE, COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 31. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 32. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 33. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 34. U.K COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 35. U.K COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 36. U.K COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 37. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 38. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 39. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 40. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 41. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 42. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 43. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 44. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 45. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 46. ROE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 47. ROE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 48. ROE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 49. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 50. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 51. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 52. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 53. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 54. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 55. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 56. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 57. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 58. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 59. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 60. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 61. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 62. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 63. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 64. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 65. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 66. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 67. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 68. BELLE SANT? DIAGNOSTIC & THERAPEUTIC INSTITUTE PVT. LTD: FINANCIALS
TABLE 69. BELLE SANT? DIAGNOSTIC & THERAPEUTIC INSTITUTE PVT. LTD: PRODUCTS & SERVICES
TABLE 70. BELLE SANT? DIAGNOSTIC & THERAPEUTIC INSTITUTE PVT. LTD: RECENT DEVELOPMENTS
TABLE 71. PHARMEDIUM HEALTHCARE HOLDINGS, INC: FINANCIALS
TABLE 72. PHARMEDIUM HEALTHCARE HOLDINGS, INC: PRODUCTS & SERVICES
TABLE 73. PHARMEDIUM HEALTHCARE HOLDINGS, INC: RECENT DEVELOPMENTS
TABLE 74. FRESENIUS KABI AG: FINANCIALS
TABLE 75. FRESENIUS KABI AG: PRODUCTS & SERVICES
TABLE 76. FRESENIUS KABI AG: RECENT DEVELOPMENTS
TABLE 77. ELIXIR COMPOUNDING PHARMACY: FINANCIALS
TABLE 78. ELIXIR COMPOUNDING PHARMACY: PRODUCTS & SERVICES
TABLE 79. ELIXIR COMPOUNDING PHARMACY: RECENT DEVELOPMENTS
TABLE 80. AVELLA SPECIALTY PHARMACY: FINANCIALS
TABLE 81. AVELLA SPECIALTY PHARMACY: PRODUCTS & SERVICES
TABLE 82. AVELLA SPECIALTY PHARMACY: RECENT DEVELOPMENTS
TABLE 83. B. BRAUN MELSUNGEN AG: FINANCIALS
TABLE 84. B. BRAUN MELSUNGEN AG: PRODUCTS & SERVICES
TABLE 85. B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
TABLE 86. TRIANGLE COMPOUNDING PHARMACY: FINANCIALS
TABLE 87. TRIANGLE COMPOUNDING PHARMACY: PRODUCTS & SERVICES
TABLE 88. TRIANGLE COMPOUNDING PHARMACY: RECENT DEVELOPMENTS
TABLE 89. VERTISIS CUSTOM PHARMACY: FINANCIALS
TABLE 90. VERTISIS CUSTOM PHARMACY: PRODUCTS & SERVICES
TABLE 91. VERTISIS CUSTOM PHARMACY: RECENT DEVELOPMENTS
TABLE 92. FAGRON, INC: FINANCIALS
TABLE 93. FAGRON, INC: PRODUCTS & SERVICES
TABLE 94. FAGRON, INC: RECENT DEVELOPMENTS
TABLE 95. US COMPOUNDING INC: FINANCIALS
TABLE 96. US COMPOUNDING INC: PRODUCTS & SERVICES
TABLE 97. US COMPOUNDING INC: RECENT DEVELOPMENTS
TABLE 1. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR HORMONE REPLACEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PAIN MANAGEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR DERMATOLOGY APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR SPECIALTY DRUGS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NUTRITIONAL SUPPLEMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PARENTERAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NASAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL INGREDIENT ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR CURRENTLY UNAVAILABLE PHARMACEUTICAL MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL DOSAGE ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 17. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 18. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 19. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 20. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 21. U.S COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 22. U.S COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 23. U.S COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 24. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 25. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 26. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 27. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 28. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 29. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 30. EUROPE COMPOUNDING PHARMACY MARKET VALUE, COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 31. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 32. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 33. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 34. U.K COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 35. U.K COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 36. U.K COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 37. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 38. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 39. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 40. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 41. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 42. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 43. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 44. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 45. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 46. ROE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 47. ROE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 48. ROE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 49. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 50. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 51. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 52. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 53. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 54. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 55. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 56. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 57. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 58. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 59. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 60. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 61. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 62. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 63. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 64. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 65. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
TABLE 66. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
TABLE 67. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
TABLE 68. BELLE SANT? DIAGNOSTIC & THERAPEUTIC INSTITUTE PVT. LTD: FINANCIALS
TABLE 69. BELLE SANT? DIAGNOSTIC & THERAPEUTIC INSTITUTE PVT. LTD: PRODUCTS & SERVICES
TABLE 70. BELLE SANT? DIAGNOSTIC & THERAPEUTIC INSTITUTE PVT. LTD: RECENT DEVELOPMENTS
TABLE 71. PHARMEDIUM HEALTHCARE HOLDINGS, INC: FINANCIALS
TABLE 72. PHARMEDIUM HEALTHCARE HOLDINGS, INC: PRODUCTS & SERVICES
TABLE 73. PHARMEDIUM HEALTHCARE HOLDINGS, INC: RECENT DEVELOPMENTS
TABLE 74. FRESENIUS KABI AG: FINANCIALS
TABLE 75. FRESENIUS KABI AG: PRODUCTS & SERVICES
TABLE 76. FRESENIUS KABI AG: RECENT DEVELOPMENTS
TABLE 77. ELIXIR COMPOUNDING PHARMACY: FINANCIALS
TABLE 78. ELIXIR COMPOUNDING PHARMACY: PRODUCTS & SERVICES
TABLE 79. ELIXIR COMPOUNDING PHARMACY: RECENT DEVELOPMENTS
TABLE 80. AVELLA SPECIALTY PHARMACY: FINANCIALS
TABLE 81. AVELLA SPECIALTY PHARMACY: PRODUCTS & SERVICES
TABLE 82. AVELLA SPECIALTY PHARMACY: RECENT DEVELOPMENTS
TABLE 83. B. BRAUN MELSUNGEN AG: FINANCIALS
TABLE 84. B. BRAUN MELSUNGEN AG: PRODUCTS & SERVICES
TABLE 85. B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
TABLE 86. TRIANGLE COMPOUNDING PHARMACY: FINANCIALS
TABLE 87. TRIANGLE COMPOUNDING PHARMACY: PRODUCTS & SERVICES
TABLE 88. TRIANGLE COMPOUNDING PHARMACY: RECENT DEVELOPMENTS
TABLE 89. VERTISIS CUSTOM PHARMACY: FINANCIALS
TABLE 90. VERTISIS CUSTOM PHARMACY: PRODUCTS & SERVICES
TABLE 91. VERTISIS CUSTOM PHARMACY: RECENT DEVELOPMENTS
TABLE 92. FAGRON, INC: FINANCIALS
TABLE 93. FAGRON, INC: PRODUCTS & SERVICES
TABLE 94. FAGRON, INC: RECENT DEVELOPMENTS
TABLE 95. US COMPOUNDING INC: FINANCIALS
TABLE 96. US COMPOUNDING INC: PRODUCTS & SERVICES
TABLE 97. US COMPOUNDING INC: RECENT DEVELOPMENTS
LIST OF FIGURES
CHART. 1. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR HORMONE REPLACEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PAIN MANAGEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR DERMATOLOGY APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR SPECIALTY DRUGS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NUTRITIONAL SUPPLEMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PARENTERAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NASAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL INGREDIENT ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR CURRENTLY UNAVAILABLE PHARMACEUTICAL MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL DOSAGE ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 17. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 18. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 19. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 20. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 21. U.S COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 22. U.S COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 23. U.S COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 24. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 25. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 26. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 27. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 28. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 29. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 30. EUROPE COMPOUNDING PHARMACY MARKET VALUE, COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 31. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 32. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 33. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 34. U.K COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 35. U.K COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 36. U.K COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 37. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 38. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 39. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 40. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 41. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 42. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 43. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 44. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 45. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 46. ROE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 47. ROE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 48. ROE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 49. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 50. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 51. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 52. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 53. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 54. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 55. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 56. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 57. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 58. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 59. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 60. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 61. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 62. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 63. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 64. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 65. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 66. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 67. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 1. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR HORMONE REPLACEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PAIN MANAGEMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR DERMATOLOGY APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR SPECIALTY DRUGS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NUTRITIONAL SUPPLEMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PARENTERAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR NASAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL INGREDIENT ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR CURRENTLY UNAVAILABLE PHARMACEUTICAL MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL COMPOUNDING PHARMACY MARKET VALUE FOR PHARMACEUTICAL DOSAGE ALTERATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 17. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 18. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 19. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 20. NORTH AMERICA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 21. U.S COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 22. U.S COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 23. U.S COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 24. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 25. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 26. CANADA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 27. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 28. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 29. EUROPE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 30. EUROPE COMPOUNDING PHARMACY MARKET VALUE, COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 31. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 32. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 33. GERMANY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 34. U.K COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 35. U.K COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 36. U.K COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 37. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 38. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 39. FRANCE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 40. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 41. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 42. ITALY COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 43. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 44. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 45. SPAIN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 46. ROE COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 47. ROE COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 48. ROE COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 49. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 50. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 51. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 52. ASIA PACIFIC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 53. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 54. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 55. CHINA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 56. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 57. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 58. INDIA COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 59. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 60. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 61. JAPAN COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 62. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 63. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 64. REST OF APAC COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
CHART. 65. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY THERAPEUTIC AREAS, 2020-2026 (USD BILLION)
CHART. 66. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY PRODUCTS, 2020-2026 (USD BILLION)
CHART. 67. REST OF WORLD COMPOUNDING PHARMACY MARKET VALUE, BY COMPOUNDING TYPES, 2020-2026 (USD BILLION)
